These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28685525)

  • 41. Microenvironmental regulation of inducible nitric oxide synthase expression and nitric oxide production in mouse bone marrow-derived mast cells.
    Moon TC; Yoshimura T; Parsons T; Befus AD
    J Leukoc Biol; 2012 Apr; 91(4):581-90. PubMed ID: 22262798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-12: Functional activities and implications for disease.
    Zundler S; Neurath MF
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):559-68. PubMed ID: 26182974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
    Jones SA; Jenkins BJ
    Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New aspect of allergic contact dermatitis, an inflammatory skin disorder mediated by mast cells: Can IL-38 help?
    Lauritano D; Ronconi G; Caraffa A; Enrica Gallenga C; Kritas SK; Di Emidio P; Martinotti S; Tetè G; Ross R; Conti P
    Med Hypotheses; 2020 Jun; 139():109687. PubMed ID: 32259663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-10 in Mast Cell-Mediated Immune Responses: Anti-Inflammatory and Proinflammatory Roles.
    Nagata K; Nishiyama C
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pLysRS-Ap
    Govindaraj S; Paruchuru LB; Razin E
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Critical role of inflammatory mast cell in fibrosis: Potential therapeutic effect of IL-37.
    Conti P; Caraffa A; Mastrangelo F; Tettamanti L; Ronconi G; Frydas I; Kritas SK; Theoharides TC
    Cell Prolif; 2018 Oct; 51(5):e12475. PubMed ID: 30062695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro.
    Dahl C; Hoffmann HJ; Saito H; Schiøtz PO
    Allergy; 2004 Oct; 59(10):1087-96. PubMed ID: 15355468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The mast cell in innate and adaptive immunity.
    Shelburne CP; Abraham SN
    Adv Exp Med Biol; 2011; 716():162-85. PubMed ID: 21713657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of mast cell development by inflammatory factors.
    Hu ZQ; Zhao WH; Shimamura T
    Curr Med Chem; 2007; 14(28):3044-50. PubMed ID: 18220740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-9 signaling as key driver of chronic inflammation in mucosal immunity.
    Neurath MF; Finotto S
    Cytokine Growth Factor Rev; 2016 Jun; 29():93-9. PubMed ID: 26976761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Asthma: the importance of dysregulated barrier immunity.
    Lambrecht BN; Hammad H
    Eur J Immunol; 2013 Dec; 43(12):3125-37. PubMed ID: 24165907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New insight into systemic mastocytosis mediated by cytokines IL-1β and IL-33: Potential inhibitory effect of IL-37.
    Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Pandolfi F
    Eur J Pharmacol; 2019 Sep; 858():172473. PubMed ID: 31228452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mast cell-mediated mechanistic pathways in organ transplantation.
    Elieh Ali Komi D; Ribatti D
    Eur J Pharmacol; 2019 Aug; 857():172458. PubMed ID: 31202799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-25: key regulator of inflammatory and autoimmune diseases.
    Saadoun D; Terrier B; Cacoub P
    Curr Pharm Des; 2011 Nov; 17(34):3781-5. PubMed ID: 22103849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation and inhibition of adaptive immune response mediated by mast cells.
    Toniato E; Frydas I; Robuffo I; Ronconi G; Caraffa Al; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2017 Jul-Sep,; 31(3):543-548. PubMed ID: 28952282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
    Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
    Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS.
    Schülke S; Flaczyk A; Vogel L; Gaudenzio N; Angers I; Löschner B; Wolfheimer S; Spreitzer I; Qureshi S; Tsai M; Galli S; Vieths S; Scheurer S
    Allergy; 2015 Oct; 70(10):1259-68. PubMed ID: 26081583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mast cells within cellular networks.
    Stassen M; Hartmann AK; Delgado SJ; Dehmel S; Braun A
    J Allergy Clin Immunol; 2019 Oct; 144(4S):S46-S54. PubMed ID: 30731122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis.
    Ribatti D
    Immunol Lett; 2013 May; 152(2):83-8. PubMed ID: 23685256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.